United States · FDA National Drug Code directory
Bupropion Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-5445_cb660c34-cfd0-4598-a767-db8a82e087e0
- Product NDC
- 0115-5445
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- BUPROPION HYDROCHLORIDE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041203
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-13) · 0115-5445-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →